Zobrazeno 1 - 10
of 28
pro vyhledávání: '"T R, Norman"'
Publikováno v:
International clinical psychopharmacology. 14(3)
The hormone melatonin is secreted at night from the pineal gland, with light being a potent inhibitor of its secretion. Age related decreases in plasma melatonin concentrations have indicated that this may be related to pineal calcification with agin
Publikováno v:
Human Psychopharmacology: Clinical and Experimental. 5:373-375
Publikováno v:
The Journal of clinical psychiatry. 59
Reboxetine is a unique selective norepinephrine reuptake inhibitor (NRI) with proven antidepressant efficacy in pharmacologic and biochemical tests predictive of antidepressant properties. Comprehensive clinical trials, including 8 placebo-controlled
Publikováno v:
The Medical journal of Australia. 167(9)
Publikováno v:
The Medical journal of Australia. 167(6)
Autor:
R, Noyes, G D, Burrows, J H, Reich, F K, Judd, M J, Garvey, T R, Norman, B L, Cook, P, Marriott
Publikováno v:
The Journal of clinical psychiatry. 57(8)
Alprazolam has proven efficacy as a treatment for panic disorder, but the place of other benzodiazepines is less well established.To compare the efficacy and tolerability of diazepam and alprazolam for the disorder, a placebo-controlled, double-blind
Publikováno v:
International clinical psychopharmacology. 9(2)
The antituberculous drug isoniazid has weak monoamine oxidase inhibiting properties. Drug and dietary restrictions generally applied to the use of monoamine oxidase inhibitors (MAOI) have not been routinely recommended with its use. Here we report th
Publikováno v:
The Journal of clinical psychiatry.
Panic disorder is characterized by unexpected, unprovoked attacks of cognitive symptoms (e.g., dread, fear) and physical symptoms (e.g., palpitations, trembling, shortness of breath). It is the most common anxiety disorder seen in clinical practice.
Autor:
F K, Judd, T R, Norman
Publikováno v:
Australian family physician. 19(9)
Depression is a common disorder. While depressive symptoms are often transient and may be regarded as normal, 10 per cent of the population suffers depressive symptoms of sufficient severity and duration to be diagnosed as suffering a depressive illn
Publikováno v:
Clinical Chemistry. 26:5-17